BT-Amide
BT-Amide is the orally active inhibitor for Pyk2 kinase with IC50 of 44.69 nM. BT-Amide prevents glucocorticoid-induced bone loss, exhibits bone protective activity in C57BL/6 mouse[1].
Product Specifications
UNSPSC
12352005
Target
Pyk2
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Metabolic Disease
Smiles
ClC1=C(N=C(N=C1)NC2=CC=C(C=C2OC)NC(CCCCC(NCCCC(P(O)(O)=O)(P(O)(O)=O)O)=O)=O)NC3=C(C=CC=C3)C(NC)=O
Molecular Formula
C29H38ClN7O11P2
Molecular Weight
758.05
References & Citations
[1]Wang X, et al., Generation of BT-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective via Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss. J Med Chem. 2024 Nov 28;67 (22) :20708-20720.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6276349-01 0.2 mL
ATOH8, NT (ATOH8, ATH6, BHLHA21, Protein atonal homolog 8, Class A basic helix-loop-helix protein 21, Helix-loop-helix protein hATH-6) (APC)
Ask
View Details 
MBS6276349-02 5x 0.2 mL
ATOH8, NT (ATOH8, ATH6, BHLHA21, Protein atonal homolog 8, Class A basic helix-loop-helix protein 21, Helix-loop-helix protein hATH-6) (APC)
Ask
View Details 
H5110-08C 100 µg
Histone H2A.X, phosphorylated (Ser139) (H2A histone family member X, H2A.FX, H2A/X, H2AFX)
Ask
View Details